Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jul;65(7):2599–2605. doi: 10.1128/iai.65.7.2599-2605.1997

Extracellular proteins of Cryptococcus neoformans and host antibody response.

L C Chen 1, L A Pirofski 1, A Casadevall 1
PMCID: PMC175368  PMID: 9199426

Abstract

Proteins secreted by the fungal pathogen Cryptococcus neoformans may be involved in invasion and could be useful in vaccine design. Despite the medical importance of this fungus, little is known about its extracellular proteins or the immune response to these antigens. To study C. neoformans extracellular proteins, 12 strains were metabolically radiolabeled and protein supernatants were analyzed. Both strain- and growth condition-dependent differences were observed. Enzymatic assays of filtered culture supernatants revealed butyrate esterase and caprylate esterase lipase activity for 11 of 12 strains, as well as acid phosphatase, naphthol-AS-BI-phosphohydrolase, and beta-glucosidase activities in some strains. Serum from infected rodents immunoprecipitated several secreted proteins, consistent with in vivo expression and development of an antibody response. For strain 24067, two immunodominant species, of approximately 75 and 30 kDa, were recognized. The relative intensity of the autoradiographic bands depended on the route of infection for both rats and mice. In summary, our results indicate that (i) there are multiple proteins in C. neoformans culture supernatants, (ii) there are strain differences in supernatant protein profiles, (iii) there are differences in supernatant protein profile depending on the growth conditions, (iv) there are several new extracellular and/or cell-associated enzymatic activities, and (v) antibodies to several supernatant proteins are made in the course of infection.

Full Text

The Full Text of this article is available as a PDF (2.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki S., Ito-Kuwa S., Nakamura K., Kato J., Ninomiya K., Vidotto V. Extracellular proteolytic activity of Cryptococcus neoformans. Mycopathologia. 1994 Dec;128(3):143–150. doi: 10.1007/BF01138475. [DOI] [PubMed] [Google Scholar]
  2. Baca O. G., Roman M. J., Glew R. H., Christner R. F., Buhler J. E., Aragon A. S. Acid phosphatase activity in Coxiella burnetii: a possible virulence factor. Infect Immun. 1993 Oct;61(10):4232–4239. doi: 10.1128/iai.61.10.4232-4239.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Belay T., Cherniak R. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay. Infect Immun. 1995 May;63(5):1810–1819. doi: 10.1128/iai.63.5.1810-1819.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Belay T., Cherniak R., O'Neill E. B., Kozel T. R. Serotyping of Cryptococcus neoformans by dot enzyme assay. J Clin Microbiol. 1996 Feb;34(2):466–470. doi: 10.1128/jcm.34.2.466-470.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bennett J. E. Cryptococcal skin test antigen: preparation variables and characterization. Infect Immun. 1981 Apr;32(1):373–380. doi: 10.1128/iai.32.1.373-380.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bhattacharjee A. K., Kwon-Chung K. J., Glaudemans C. P. The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D. Carbohydr Res. 1979 Aug;73:183–192. doi: 10.1016/s0008-6215(00)85488-9. [DOI] [PubMed] [Google Scholar]
  7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  8. Buchanan K. L., Murphy J. W. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun. 1993 Jul;61(7):2854–2865. doi: 10.1128/iai.61.7.2854-2865.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Casal M., Linares M. J. Contribution to the study of the enzymatic profiles of yeast organisms with medical interest. Mycopathologia. 1983 Mar 22;81(3):155–159. doi: 10.1007/BF00436820. [DOI] [PubMed] [Google Scholar]
  10. Chang Y. C., Penoyer L. A., Kwon-Chung K. J. The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun. 1996 Jun;64(6):1977–1983. doi: 10.1128/iai.64.6.1977-1983.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chen L. C., Blank E. S., Casadevall A. Extracellular proteinase activity of Cryptococcus neoformans. Clin Diagn Lab Immunol. 1996 Sep;3(5):570–574. doi: 10.1128/cdli.3.5.570-574.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cherniak R., Sundstrom J. B. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun. 1994 May;62(5):1507–1512. doi: 10.1128/iai.62.5.1507-1512.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Comménil P., Belingheri L., Sancholle M., Dehorter B. Purification and properties of an extracellular lipase from the fungus Botrytis cinerea. Lipids. 1995 Apr;30(4):351–356. doi: 10.1007/BF02536044. [DOI] [PubMed] [Google Scholar]
  14. Currie B. P., Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis. 1994 Dec;19(6):1029–1033. doi: 10.1093/clinids/19.6.1029. [DOI] [PubMed] [Google Scholar]
  15. Currie B. P., Freundlich L. F., Casadevall A. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol. 1994 May;32(5):1188–1192. doi: 10.1128/jcm.32.5.1188-1192.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Curtis J. L., Huffnagle G. B., Chen G. H., Warnock M. L., Gyetko M. R., McDonald R. A., Scott P. J., Toews G. B. Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab Invest. 1994 Jul;71(1):113–126. [PubMed] [Google Scholar]
  17. De Reuck J. L., De Coster W. J., vander Eecken H. M. Acid phosphatase activity of cerebrospinal fluid cells in bacterial and abacterial meningitis. Eur Neurol. 1986;25(5):362–368. doi: 10.1159/000116035. [DOI] [PubMed] [Google Scholar]
  18. Feldmesser M., Casadevall A. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J Immunol. 1997 Jan 15;158(2):790–799. [PubMed] [Google Scholar]
  19. Fromtling R. A., Shadomy H. J., Jacobson E. S. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia. 1982 Jul 23;79(1):23–29. doi: 10.1007/BF00636177. [DOI] [PubMed] [Google Scholar]
  20. Goldman D., Lee S. C., Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun. 1994 Nov;62(11):4755–4761. doi: 10.1128/iai.62.11.4755-4761.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Graybill J. R., Straus D. C., Nealon T. J., Hague M., Paque R. E. Immunogenic fractions of Cryptococcus neoformans. Mycopathologia. 1982 Apr 23;78(1):31–39. doi: 10.1007/BF00436579. [DOI] [PubMed] [Google Scholar]
  22. Hamilton A. J., Bartholomew M. A., Figueroa J., Fenelon L. E., Hay R. J. Production of species-specific murine monoclonal antibodies against Cryptococcus neoformans which recognize a noncapsular exoantigen. J Clin Microbiol. 1991 May;29(5):980–984. doi: 10.1128/jcm.29.5.980-984.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hamilton A. J., Goodley J. Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by immune sera. J Clin Microbiol. 1993 Feb;31(2):335–339. doi: 10.1128/jcm.31.2.335-339.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hamilton A. J., Jeavons L., Hobby P., Hay R. J. A 34- to 38-kilodalton Cryptococcus neoformans glycoprotein produced as an exoantigen bearing a glycosylated species-specific epitope. Infect Immun. 1992 Jan;60(1):143–149. doi: 10.1128/iai.60.1.143-149.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hay R. J., Reiss E. Delayed-type hypersensitivity responses in infected mice elicited by cytoplasmic fractions of Cryptococcus neoformans. Infect Immun. 1978 Oct;22(1):72–79. doi: 10.1128/iai.22.1.72-79.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hoag K. A., Street N. E., Huffnagle G. B., Lipscomb M. F. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol. 1995 Oct;13(4):487–495. doi: 10.1165/ajrcmb.13.4.7546779. [DOI] [PubMed] [Google Scholar]
  27. Ibrahim A. S., Mirbod F., Filler S. G., Banno Y., Cole G. T., Kitajima Y., Edwards J. E., Jr, Nozawa Y., Ghannoum M. A. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun. 1995 May;63(5):1993–1998. doi: 10.1128/iai.63.5.1993-1998.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ito A., Mukaiyama A., Itoh Y., Nagase H., Thogersen I. B., Enghild J. J., Sasaguri Y., Mori Y. Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem. 1996 Jun 21;271(25):14657–14660. doi: 10.1074/jbc.271.25.14657. [DOI] [PubMed] [Google Scholar]
  29. Jacobson E. S., Ayers D. J., Harrell A. C., Nicholas C. C. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol. 1982 Jun;150(3):1292–1296. doi: 10.1128/jb.150.3.1292-1296.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Jacobson E. S., Tingler M. J. Strains of Cryptococcus neoformans with defined capsular phenotypes. J Med Vet Mycol. 1994;32(5):401–404. [PubMed] [Google Scholar]
  31. Kalina M., Bubis J. J., Kletter Y., Shahar A., Aronson M. Ultrastructural localization of acid phosphatase in the yeast Cryptococcus neoformans. Experientia. 1970 Mar 15;26(3):287–288. doi: 10.1007/BF01900099. [DOI] [PubMed] [Google Scholar]
  32. Kozel T. R. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans. Infect Immun. 1983 Mar;39(3):1214–1219. doi: 10.1128/iai.39.3.1214-1219.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kozel T. R., Wilson M. A., Murphy J. W. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect Immun. 1991 Sep;59(9):3101–3110. doi: 10.1128/iai.59.9.3101-3110.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. König B., Jaeger K. E., Sage A. E., Vasil M. L., König W. Role of Pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes. Infect Immun. 1996 Aug;64(8):3252–3258. doi: 10.1128/iai.64.8.3252-3258.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Maeda H., Yamamoto T. Pathogenic mechanisms induced by microbial proteases in microbial infections. Biol Chem Hoppe Seyler. 1996 Apr;377(4):217–226. doi: 10.1515/bchm3.1996.377.4.217. [DOI] [PubMed] [Google Scholar]
  36. Mahvi T. A., Spicer S. S., Wright N. J. Cytochemistry of acid mucosubstance and acid phosphatase in Cryptococcus neoformans. Can J Microbiol. 1974 Jun;20(6):833–838. doi: 10.1139/m74-128. [DOI] [PubMed] [Google Scholar]
  37. Mirbod F., Banno Y., Ghannoum M. A., Ibrahim A. S., Nakashima S., Kitajima Y., Cole G. T., Nozawa Y. Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans. Biochim Biophys Acta. 1995 Jul 13;1257(2):181–188. doi: 10.1016/0005-2760(95)00072-k. [DOI] [PubMed] [Google Scholar]
  38. Mody C. H., Sims K. L., Wood C. J., Syme R. M., Spurrell J. C., Sexton M. M. Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferate. Infect Immun. 1996 Nov;64(11):4811–4819. doi: 10.1128/iai.64.11.4811-4819.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Mukherjee J., Pirofski L. A., Scharff M. D., Casadevall A. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3636–3640. doi: 10.1073/pnas.90.8.3636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Mukherjee J., Scharff M. D., Casadevall A. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun. 1992 Nov;60(11):4534–4541. doi: 10.1128/iai.60.11.4534-4541.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Murphy J. W., Cozad G. C. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun. 1972 Jun;5(6):896–901. doi: 10.1128/iai.5.6.896-901.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Murphy J. W., Gregory J. A., Larsh H. W. Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect Immun. 1974 Feb;9(2):404–409. doi: 10.1128/iai.9.2.404-409.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Murphy J. W., Mosley R. L., Cherniak R., Reyes G. H., Kozel T. R., Reiss E. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun. 1988 Feb;56(2):424–431. doi: 10.1128/iai.56.2.424-431.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Murphy J. W., Pahlavan N. Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis. Infect Immun. 1979 Jul;25(1):284–292. doi: 10.1128/iai.25.1.284-292.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Perfect J. R., Hobbs M. M., Granger D. L., Durack D. T. Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect Immun. 1988 Apr;56(4):849–854. doi: 10.1128/iai.56.4.849-854.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Reilly T. J., Baron G. S., Nano F. E., Kuhlenschmidt M. S. Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis. J Biol Chem. 1996 May 3;271(18):10973–10983. doi: 10.1074/jbc.271.18.10973. [DOI] [PubMed] [Google Scholar]
  47. Reiss E., Cherniak R., Eby R., Kaufman L. Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans. Diagn Immunol. 1984;2(2):109–115. [PubMed] [Google Scholar]
  48. Ross A., Taylor I. E. Extracellular glycoprotein from virulent and avirulent Cryptococcus species. Infect Immun. 1981 Mar;31(3):911–918. doi: 10.1128/iai.31.3.911-918.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Saha A. K., Dowling J. N., LaMarco K. L., Das S., Remaley A. T., Olomu N., Pope M. T., Glew R. H. Properties of an acid phosphatase from Legionella micdadei which blocks superoxide anion production by human neutrophils. Arch Biochem Biophys. 1985 Nov 15;243(1):150–160. doi: 10.1016/0003-9861(85)90783-0. [DOI] [PubMed] [Google Scholar]
  50. Sakata Y., Akaike T., Suga M., Ijiri S., Ando M., Maeda H. Bradykinin generation triggered by Pseudomonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa. Microbiol Immunol. 1996;40(6):415–423. doi: 10.1111/j.1348-0421.1996.tb01088.x. [DOI] [PubMed] [Google Scholar]
  51. Tsuboi R., Komatsuzaki H., Ogawa H. Induction of an extracellular esterase from Candida albicans and some of its properties. Infect Immun. 1996 Aug;64(8):2936–2940. doi: 10.1128/iai.64.8.2936-2940.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Turner S. H., Cherniak R., Reiss E. Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res. 1984 Feb 15;125(2):343–349. doi: 10.1016/0008-6215(84)85172-1. [DOI] [PubMed] [Google Scholar]
  53. Vartivarian S. E., Reyes G. H., Jacobson E. S., James P. G., Cherniak R., Mumaw V. R., Tingler M. J. Localization of mannoprotein in Cryptococcus neoformans. J Bacteriol. 1989 Dec;171(12):6850–6852. doi: 10.1128/jb.171.12.6850-6852.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wang Y., Aisen P., Casadevall A. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect Immun. 1996 Jul;64(7):2420–2424. doi: 10.1128/iai.64.7.2420-2424.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wang Y., Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun. 1994 Jul;62(7):3004–3007. doi: 10.1128/iai.62.7.3004-3007.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wickes B. L., Moore T. D., Kwon-Chung K. J. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology. 1994 Mar;140(Pt 3):543–550. doi: 10.1099/00221287-140-3-543. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES